BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/19/2017 8:53:34 PM | Browse: 277 | Download: 555
Publication Name World Journal of Gastroenterology
Manuscript ID 35260
Country Finland
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series
Manuscript Source Unsolicited Manuscript
All Author List Perttu Lahtinen, Eero Mattila, Veli-Jukka Anttila, Jyrki Tillonen, Matti Teittinen, Pasi Nevalainen, Seppo Salminen, Reetta Satokari and Perttu Arkkila
Funding Agency and Grant Number
Corresponding Author Perttu Lahtinen, MD, Department of Gastroenterology, Päijät-Häme Central Hospital, Keskussairaalankatu 7, Lahti 15610, Finland. perttupaavali@gmail.com
Key Words Faecal microbiota transplantation; Antibiotic resistance; Clostridium difficile infection; Microbiota; Immunodeficiency; Salmonella infection
Core Tip Knowledge of faecal microbiota transplantation (FMT) in immunocompromised patients and patients with conditions other than recurrent Clostridium difficile infection (rCDI) is scarce. We reviewed 13 FMT-treated patients with rCDI and major comorbidities as well as 8 patients with new indications. In our cohort, FMT appeared to be safe and effective for immuno­compromised patients: dialysis patients, human immu­nodeficiency virus patients, solid organ trans­plant patients and a patient with chronic lymphatic leuka­emia. Of the patients treated for indications other than rCDI, the most promising results were successful eradication of antibiotic-resistant bacteria. Eradication of chronic Salmonella carriage in two patients with FMT represents the first cases reported to date.
Citation Lahtinen P, Mattila E, Anttila VJ, Tillonen J, Teittinen M, Nevalainen P, Salminen S, Satokari R, Arkkila P. Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series. World J Gastroenterol 2017; 23(39): 7174-7184
Received
2017-07-31 00:19
Peer-Review Started
2017-07-31 00:59
To Make the First Decision
2017-08-15 03:40
Return for Revision
2017-08-16 09:27
Revised
2017-09-08 11:23
Second Decision
2017-09-15 00:06
Accepted by Journal Editor-in-Chief
2017-09-15 16:06
Accepted by Company Editor-in-Chief
2017-09-19 20:53
Articles in Press
2017-09-19 20:53
Publication Fee Transferred
2017-09-21 06:29
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-10-18 03:03
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com